Prospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Surg. Dec 27, 2022; 14(12): 1375-1386
Published online Dec 27, 2022. doi: 10.4240/wjgs.v14.i12.1375
Table 1 Patient demographics and tumor characteristics
Variable
n = 43
Age: Median (IQR), yr57 (47-65)
Sex: Male/female, n29/14
BMI: Median (IQR), kg/m222.40 (19.50-23.95)
ASA class, n (%)
18 (18.6)
230 (69.8)
35 (11.6)
40
Tumor size: Median (IQR), cm2.5 (2.0-3.8)
Tumor height1: Median (IQR), cm4.0 (3.6-4.6)
Histological subtype, n (%)
Adenocarcinoma39 (90.7)
Mucinous adenocarcinoma/signet ring cell carcinoma4 (9.3)
Differentiation grade, n (%)
Well7 (16.3)
Moderate32 (74.4)
Poor4 (9.3)
Neoadjuvant chemoradiotherapy, n (%)21 (48.8)
TRG2, n (%)
Grade 03 (7.0)
Grade 110 (23.3)
Grade 27 (14.0)
Grade 31 (2.3)
T stage, n (%)
T05 (11.6)
T14 (9.3)
T217 (39.5)
T313 (30.2)
T44 (9.3)
N stage, n (%)
N030 (69.8)
N110 (23.3)
N23 (7.0)
M stage, n (%)
M043 (100)
M10